Literature DB >> 18175341

Cortical excitability is abnormal in patients with the "fixed dystonia" syndrome.

Laura Avanzino1, Davide Martino, Bart P C van de Warrenburg, Susanne A Schneider, Giovanni Abbruzzese, Giovanni Defazio, Anette Schrag, Kailash P Bhatia, John C Rothwell.   

Abstract

A form of fixed dystonia (FD) without evidence of basal ganglia lesions or neurodegeneration has been recently characterized (Schrag et al., Brain 2004;127:2360-2372), which may overlap the clinical spectrum of either complex regional pain syndrome or psychogenic dystonia. Transcranial magnetic stimulation studies in typically mobile dystonia revealed abnormal motor cortical excitability and sensori-motor integration. We compared 12 patients with limb FD to 10 patients with primary adult-onset typically mobile dystonia and 11 age-matched healthy volunteers. Measurements at the first digital interosseus representation area on both hemispheres included: short intracortical inhibition (SICI), contralateral silent period (cSP), and short and long afferent inhibition (SAI and LAI). Repeated measure ANOVA and post-hoc t-tests were used for statistical analysis. SICI was significantly reduced in both hemispheres of patients with "typical" and FD, compared to healthy subjects. For both hemispheres, cSP duration was shorter in both fixed and "typical" dystonia patients. SAI and LAI did not significantly differ between the three groups. The abnormal cortical excitability observed in FD might represent an underlying trait predisposing to different clinical forms of dystonia. 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2008        PMID: 18175341     DOI: 10.1002/mds.21801

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  Physiology of psychogenic movement disorders.

Authors:  Mark Hallett
Journal:  J Clin Neurosci       Date:  2010-05-20       Impact factor: 1.961

Review 2.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

3.  Abnormal sensorimotor plasticity in organic but not in psychogenic dystonia.

Authors:  A Quartarone; V Rizzo; C Terranova; F Morgante; S Schneider; N Ibrahim; P Girlanda; K P Bhatia; J C Rothwell
Journal:  Brain       Date:  2009-08-18       Impact factor: 13.501

Review 4.  Clinical features and pathophysiology of complex regional pain syndrome.

Authors:  Johan Marinus; G Lorimer Moseley; Frank Birklein; Ralf Baron; Christian Maihöfner; Wade S Kingery; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

Review 5.  Phenotype-specific diagnosis of functional (psychogenic) movement disorders.

Authors:  Alberto J Espay; Anthony E Lang
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

Review 6.  Delineating the electrophysiological signature of dystonia.

Authors:  Anna Latorre; Lorenzo Rocchi; Kailash P Bhatia
Journal:  Exp Brain Res       Date:  2020-07-25       Impact factor: 1.972

7.  Temporal discrimination threshold with healthy aging.

Authors:  Vesper Fe Marie Llaneza Ramos; Alina Esquenazi; Monica Anne Faye Villegas; Tianxia Wu; Mark Hallett
Journal:  Neurobiol Aging       Date:  2016-04-21       Impact factor: 4.673

8.  Normal eyeblink classical conditioning in patients with fixed dystonia.

Authors:  Sabine Janssen; Lidwien C Veugen; Britt S Hoffland; Panagiotis Kassavetis; Diana E van Rooijen; Dick F Stegeman; Mark J Edwards; Jacobus J van Hilten; Bart P van de Warrenburg
Journal:  Exp Brain Res       Date:  2014-03-05       Impact factor: 1.972

Review 9.  The Phenomenology of Functional (Psychogenic) Dystonia.

Authors:  Christos Ganos; Mark J Edwards; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

10.  The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm.

Authors:  P Schwingenschuh; P Katschnig; M J Edwards; J T H Teo; L V P Korlipara; J C Rothwell; K P Bhatia
Journal:  Neurology       Date:  2011-02-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.